Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The global pharmaceutical contract manufacturing/contract research market is anticipated to reach USD 238.3 billion by 2025, according to a new report by Grand View Research.
read more
Industry Standard Research (ISR) has announced the availability of the "Contract Manufacturer Quality Benchmarking (2015)" report, providing a comprehensive assessment of CMO service quality.
read more
The report, Global Active Pharmaceutical Ingredients Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. ...
read more
Wednesday, September 28, 2016
The global contract manufacturing organization (CMO) market is transforming to leverage changes in the pharmaceutical industry. Pharmaceutical companies continue to gain financially and overcome marketplace challenges, source innovative ideas, ...
read more
The market for drug discovery tasks that outsourced by pharmaceutical companies to contract research organizations (CROs) and others is estimated to reach $21 billion in 2016, according to Kalorama Information.
read more
The global pharmaceutical analytical testing outsourcing market is expected to reach $9.6 billion by 2025 according to a recent report by Research and Markets.
read more
Thursday, November 05, 2015
The U.S. health care system saved a record $254 billion in 2014 from generic drugs, which amounts to $1.68 trillion over the most recent decade (2005-2014), according to the seventh annual Generic Drug Savings in the United States report compiled by ...
read more
The U.S. Food and Drug Administration's (FDA) recent approval of Zarxio (filgrastim-sndz) -- the first biosimilar product approved in the United States -- points toward growth in the contract manufacturing organization (CMO) industry, according to ...
read more
Research and Markets has announced the addition of the "Biotechnology/Pharmaceutical Services Outsourcing Market Analysis, By Service And Segment Forecasts, 2014 - 2025" report to their offering.
read more
Thursday, December 22, 2016
The global biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025, according to a new report by Grand View Research, Inc. The Pharmaceutical industry has been adaptive of the function of outsourcing certain clinical ...
read more
Wednesday, December 05, 2018
The global biopharmaceuticals contract manufacturing market size is expected to reach USD 21.7 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 7.5% during the forecast period.
read more
Wednesday, February 24, 2016
Deceleration of the pharmaceutical patent cliff, combined with expectations of a patent 'slope' for biologics, will support innovative drug manufacturers' U.S. sales, according to the first report in Fitch Ratings' 'Navigating the Pharmaceutical ...
read more
Although complexities inherent in biological drug manufacturing are creating barriers for further expansion of the biosimilars market, imminent patent expiries of key biologics are set to create new opportunities for biosimilar manufacturers, ...
read more
Univercells Technologies announced a collaboration with Repligen Corporation to integrate real-time monitoring capabilities and enhance the development and manufacturing of viral vectors and vaccines.
read more
Rephine announced its merger with Barcelona-based GxP audit organization Forum Auditorias and its technology and manufacturing supply chain compliance consultancy TDV.
read more